Caplin Point Laboratories Ltd. (CAPLIPOINT) Share Price Surges 6.36% Today

Caplin Point Laboratories Ltd. Share Price rises 6.36% today, reaching Rs 2,621.5 with a market cap of Rs 18,734.22 crore.

Caplin Point Laboratories Ltd. Share Price has surged by 6.36% today, reaching Rs 2,621.5. This significant price rise places the company’s market capitalisation at Rs 18,734.22 crore. The stock’s performance today is noteworthy as it surpasses the qualifying threshold of 5% set for the Mid Cap category. Investors and analysts are closely monitoring this development, as the price action suggests increased interest and activity in the stock.

The share price opened at Rs 2,465 and quickly gained momentum, reaching a high of Rs 2,638.95. The day’s low was recorded at Rs 2,465, indicating a strong upward movement throughout the trading session. The total volume of shares traded today was 254,440, with a turnover of Rs 2.41 crore. This heightened activity reflects a substantial increase in investor participation compared to the average trading volumes.

Caplin Point Laboratories Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 2,621.5
Previous Close	Rs 2,464.65
Today's Change	+Rs 156.85 (+6.36%)
Day Open	Rs 2,465
Day High	Rs 2,638.95
Day Low	Rs 2,465
Current Volume (BSE)	9,181
BSE Traded Volume	9,181
NSE Traded Volume	2,45,259
Combined NSE + BSE Volume	2,54,440
Turnover	Rs 2.41 crore
Market Capitalisation	Rs 18,734.22 crore
Market Cap Category	Mid Cap
Qualifying Threshold Cleared	5%

Today’s trading session for Caplin Point Laboratories Ltd. has been marked by a significant price rise of 6.36%, with the share price closing at Rs 2,621.5. The previous close was Rs 2,464.65, and the stock opened at Rs 2,465, indicating a strong start to the day. The day’s high of Rs 2,638.95 and low of Rs 2,465 demonstrate a robust upward trend.

The stock’s performance today qualifies it as a top gainer in the Mid Cap category, having surpassed the 5% threshold. The total volume traded was 254,440 shares, with a turnover of Rs 2.41 crore. This volume is significantly higher than the average, indicating increased investor interest and activity in the stock.

The market capitalisation of Caplin Point Laboratories Ltd. now stands at Rs 18,734.22 crore, reflecting its position within the Mid Cap category. The price action today suggests a positive sentiment among investors, driving the share price higher. This development warrants further analysis of the company’s technical and fundamental aspects to understand the underlying factors contributing to this price movement.

Caplin Point Laboratories Ltd. Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 18,734.22 crore
P/E Ratio	31.07x
P/B Ratio	2.36x
ROE	29.2%
ROCE	27.13%

Caplin Point Laboratories Ltd. was valued at a P/E ratio of 31.07x, a P/B ratio of 2.36x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 29.2% and ROCE of 27.13%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Caplin Point Laboratories Ltd. is currently valued with a market capitalisation of Rs 18,734.22 crore. The company’s P/E ratio stands at 31.07, which is above the sector median of 20.79 but aligns with the peer Morepen Laboratories Ltd. The P/B ratio is 2.36, slightly above the sector median of 1.89, indicating a moderate valuation.

The company’s return on equity (ROE) is an impressive 29.2%, significantly higher than the sector median of 10.69%. Similarly, the return on capital employed (ROCE) is 27.13%, which is well above the sector median of 13.12%. These figures suggest strong profitability and efficient capital utilisation compared to sector peers.

While the company’s valuation multiples are higher than the sector medians, the robust ROE and ROCE provide a compelling case for investor interest. The company’s ability to generate returns on equity and capital employed is a key factor in its current market performance. Investors may find the company’s financial metrics attractive, given the strong profitability indicators.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Companies in Benchmark	203
Company P/E Ratio	31.07x
Benchmark Median P/E	20.79x
Benchmark Average P/E	67.01x
Benchmark P/E Range	0x to 3,482.29x
Companies with P/E Data	203
Company P/B Ratio	2.36x
Benchmark Median P/B	1.89x
Company ROE	29.2%
Benchmark Median ROE	10.69%
Company ROCE	27.13%
Benchmark Median ROCE	13.12%
Company Market Capitalisation	Rs 18,734.22 crore
Benchmark Median Market Cap	Rs 130.49 crore

Caplin Point Laboratories Ltd. (CAPLIPOINT) is classified under sector: Healthcare. The numerical benchmark uses 203 same sector companies from the supplied master-data set.

Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 31.07x, which is above the benchmark median of 20.79x, a difference of +49.45%. The benchmark contains 203 companies with P/E data, ranging from 0x to 3,482.29x. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROE of 29.2%, which is above the benchmark median of 10.69%, a difference of +173.15%. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a ROCE of 27.13%, which is above the benchmark median of 13.12%, a difference of +106.78%.

Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Caplin Point Laboratories Ltd. operates within the Healthcare sector, which comprises 203 companies. The sector’s P/E median is 20.79, with an average of 67.01, indicating a wide range of valuations. Caplin Point’s P/E of 31.07 is above the median but below the average, suggesting a balanced valuation within the sector context.

The sector’s P/B median is 1.89, with Caplin Point’s P/B at 2.36, indicating a slightly higher valuation compared to the sector median. The company’s ROE of 29.2% and ROCE of 27.13% are significantly above the sector medians of 10.69% and 13.12%, respectively, highlighting its superior profitability metrics.

The Healthcare sector’s market capitalisation ranges from Rs 2.09 crore to Rs 2,947.44 crore, with Caplin Point’s market cap of Rs 18,734.22 crore positioning it as a major player within the sector. The company’s strong financial performance and market position make it a noteworthy entity in the Healthcare industry.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Morepen Laboratories Ltd.	MOREPENLAB	2,947.44	31.07	2.36	29.2	27.13
Dishman Carbogen Amcis Ltd.	DCAL	2,885.59	29.61	0.43	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,881.37	42.78	8.71	28.21	26.35
Beta Drugs Ltd.	BETA	2,567.04	61.88	8.27	18.65	22.17
Dr Agarwals Eye Hospital Ltd.	DRAGARWQ	2,425.38	34.6	7	-2.6	16.92

Caplin Point Laboratories Ltd. (CAPLIPOINT) has a P/E ratio of 31.07x compared with the displayed peer median of 34.6x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 29.2% compares with a peer median of 18.65% across the companies shown in the table. ROCE stood at 27.13% versus the displayed peer median of 22.17%, providing a capital-efficiency comparison. Caplin Point Laboratories Ltd. (CAPLIPOINT) has a market capitalisation of Rs 18,734.22 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

In comparison to its peers, Caplin Point Laboratories Ltd. holds a competitive position. Morepen Laboratories Ltd. shares the same P/E ratio of 31.07, while Kwality Pharmaceuticals Ltd. has a higher P/E of 42.78. Caplin Point’s ROE of 29.2% is superior to Kwality Pharmaceuticals’ 28.21% and significantly better than Dishman Carbogen Amcis Ltd.’s negative ROE of -2.89%.

The company’s ROCE of 27.13% is also higher than that of Beta Drugs Ltd., which stands at 22.17%. Caplin Point’s market capitalisation of Rs 18,734.22 crore is larger than its peers, indicating its strong market presence. These comparisons highlight Caplin Point’s robust financial metrics and competitive edge within the industry.

Why Investors Are Watching Caplin Point Laboratories Ltd.

Investors are closely monitoring Caplin Point Laboratories Ltd. due to its recent price surge and strong financial metrics.

• Significant 6.36% price rise today, surpassing the Mid Cap threshold.
• Strong ROE of 29.2% and ROCE of 27.13%, indicating profitability.
• Valuation metrics align with sector and peer benchmarks.
• Robust market presence with a market cap of Rs 18,734.22 crore.

As the company continues to demonstrate strong financial performance, investors should monitor its future developments and market trends to assess potential opportunities.

About Caplin Point Laboratories Ltd.

Caplin Point Laboratories Ltd. is a prominent player in the Healthcare sector, focusing on the development and manufacturing of pharmaceutical products. The company operates across various segments, providing a diverse range of healthcare solutions. Its product portfolio includes formulations, APIs, and other pharmaceutical products, catering to both domestic and international markets.

With a strong emphasis on quality and innovation, Caplin Point Laboratories Ltd. has established a significant presence in the industry. The company’s strategic initiatives and focus on research and development have positioned it as a key player in the pharmaceutical sector. Its commitment to delivering high-quality healthcare solutions continues to drive its growth and market presence.

Track Caplin Point Laboratories Ltd. Share Price on Univest

Use Caplin Point Laboratories Ltd. (CAPLIPOINT) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors can track the live share price of Caplin Point Laboratories Ltd. on Univest, along with detailed technical indicators, fundamental ratios, and shareholding patterns. Univest provides comprehensive market insights, including 52-week levels and sector performance, enabling investors to make informed decisions. Stay updated with the latest developments and market trends by following Caplin Point Laboratories Ltd. on Univest.

Frequently Asked Questions

What is the current share price of Caplin Point Laboratories Ltd.?

Ans. The current share price of Caplin Point Laboratories Ltd. is Rs 2,621.5, reflecting a 6.36% increase from the previous close of Rs 2,464.65. The stock moved 6.36% during the session.

How much did Caplin Point Laboratories Ltd. share price rise today?

Ans. Caplin Point Laboratories Ltd. share price rose by 6.36% today, marking a significant gain in the Mid Cap category. The stock moved 6.36% during the session. The intraday range extended from Rs 2,465 to Rs 2,638.95.

What is the market capitalisation of Caplin Point Laboratories Ltd.?

Ans. The market capitalisation of Caplin Point Laboratories Ltd. is Rs 18,734.22 crore, positioning it within the Mid Cap category. The company operates in the Healthcare sector. Its P/E ratio is 31.07x.

How does Caplin Point Laboratories Ltd.'s P/E ratio compare to the sector median?

Ans. Caplin Point Laboratories Ltd.'s P/E ratio of 31.07 is above the sector median of 20.79, indicating a higher valuation. The company trades at a P/E ratio of 31.07x. Its P/B ratio is 2.36x.

What is the ROE of Caplin Point Laboratories Ltd.?

Ans. The return on equity (ROE) of Caplin Point Laboratories Ltd. is 29.2%, significantly higher than the sector median of 10.69%. ROE stands at 29.2%. ROCE stands at 27.13%. The relevant peer median ROE is 10.69%.

How does Caplin Point Laboratories Ltd.'s ROCE compare to the sector median?

Ans. Caplin Point Laboratories Ltd.'s ROCE of 27.13% is well above the sector median of 13.12%, indicating strong capital efficiency. ROE stands at 29.2%. ROCE stands at 27.13%. The relevant peer median ROE is 10.69%.

What is the P/B ratio of Caplin Point Laboratories Ltd.?

Ans. The P/B ratio of Caplin Point Laboratories Ltd. is 2.36, slightly above the sector median of 1.89, suggesting a moderate valuation. The company trades at a P/E ratio of 31.07x.

Who are Caplin Point Laboratories Ltd.'s peers?

Ans. Caplin Point Laboratories Ltd.'s peers include Morepen Laboratories Ltd., Dishman Carbogen Amcis Ltd., and Kwality Pharmaceuticals Ltd. Comparable listed companies include Morepen Laboratories Ltd., Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd.

What sector does Caplin Point Laboratories Ltd. operate in?

Ans. Caplin Point Laboratories Ltd. operates in the Healthcare sector, focusing on pharmaceutical products and solutions. The stock belongs to the Healthcare sector. 203 comparable companies were included in the benchmark.